Updated Data From Eledon Pharmaceuticals' Ongoing Phase 1B Trial Of Tegoprubart In Patients Undergoing Kidney Transplantation To Be Presented At The World Transplant Congress 2025

  • Allan Kirk

Press/Media

Period17 Jul 2025

Media coverage

1

Media coverage

  • TitleUpdated Data From Eledon Pharmaceuticals' Ongoing Phase 1B Trial Of Tegoprubart In Patients Undergoing Kidney Transplantation To Be Presented At The World Transplant Congress 2025
    Media name/outletMENAFN - Press Releases (English)
    Country/TerritoryJordan
    Date17/07/25
    PersonsAllan Kirk
View all 1
View less